A detailed history of Fishman Jay A LTD transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Fishman Jay A LTD holds 15,000 shares of TYRA stock, worth $250,500. This represents 0.03% of its overall portfolio holdings.

Number of Shares
15,000
Holding current value
$250,500
% of portfolio
0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$11.61 - $20.0 $174,150 - $300,000
15,000 New
15,000 $245,000
Q2 2023

Aug 15, 2023

BUY
$11.99 - $17.51 $263,780 - $385,220
22,000 New
22,000 $374,000
Q4 2022

Feb 13, 2023

BUY
$5.68 - $8.81 $65,320 - $101,315
11,500 Added 109.52%
22,000 $167,000
Q3 2022

Oct 26, 2022

BUY
$6.61 - $12.42 $69,405 - $130,410
10,500 New
10,500 $92,000

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $701M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Fishman Jay A LTD Portfolio

Follow Fishman Jay A LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fishman Jay A LTD with notifications on news.